Target intelligence / Profile preview

Activating transcription factor 2 (ATF2)

Target
ATF2
Molecular classification
Transcription factor, Histone acetyltransferase, Leucine zipper DNA-binding protein
01

Overview

Activating transcription factor 2 (ATF2) is a member of the leucine zipper family of transcription factors, encoded by the ATF2 gene in humans. It binds to cAMP-responsive elements (CRE) in DNA and can form homodimers or heterodimers, notably with c-Jun. ATF2 also acts as a histone acetyltransferase, specifically acetylating histones H2B and H4, which influences chromatin structure and transcriptional activation. The protein is activated by stress signals such as those mediated by the p38 and JNK MAP kinases, and by the DNA damage response via ATM-dependent phosphorylation. ATF2 plays diverse roles in regulating cell growth, apoptosis, DNA repair, and development, and can contribute to both oncogenesis and tumor suppression depending on cellular context. Dysregulation of ATF2 impacts several human diseases, including cancer and cardiomyopathies.

Other names
CREB2CREBP1cAMP-dependent transcription factor ATF-2CREB-2cAMP-responsive element-binding protein 2TREB7CRE-BP1HB16Cyclic AMP-dependent transcription factor ATF-2Cyclic AMP-responsive element-binding protein 2histone acetyltransferase ATF2
02

Mechanism of action

Modulation of CRE-dependent transcription via dimerization or phosphorylation; Alteration of chromatin state through histone acetylation; Regulation of apoptotic pathways and DNA damage response

03

Biological functions

Transcriptional regulationChromatin modification through histone acetylationDNA damage responseCell developmentCell proliferationCell deathStress response
04

Disease associations

Cancer (oncogenesis, tumor suppression)CardiomyopathyRetinoblastomaCancer aggressivenessRadiation sensitivityInflammation
05

Safety considerations

Oncogenic activation risk (potential to induce cancer in some tissues)Context-dependent tumor suppressor/oncogene activities
06

Biomarkers

Phosphorylation state of ATF2 (marker for DNA damage response)Histone acetylation levels

Beyond the preview

Go deeper on Activating transcription factor 2 (ATF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activating transcription factor 2 (ATF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call